The number of people with susceptibility test result for rifampicin in Vanuatu

Vanuatu: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile

Latest (2021)
0
Change on year
down 100.0%
World rank
146th
of 155 countries
All-time high
52
in 2019
All-time low
0
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Vanuatu, 2017–2021

02040602017201920212017: 462018: 412019: 522020: 432021: 0

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for the number of people with susceptibility test result for rifampicin in Vanuatu is 0, measured in 2021. That is the lowest value across all 5 years on record.

That represents a change of down 100.0% on the previous year and down 100.0% over five years.

That places Vanuatu 146th out of 155 countries with data for 2021, putting it in the bottom quarter.

The number of people with susceptibility test result for rifampicin in Vanuatu, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Vanuatu, 2017 to 2021.
Year Value Change
2017 46
2018 41 -10.9%
2019 52 +26.8%
2020 43 -17.3%
2021 0 -100.0%

Vanuatu compared with similar countries

  • Vanuatu's 0 is below the median for lower middle income countries, which is 2,804. (32 countries reporting)
  • Vanuatu's 0 is below the median for East Asia & Pacific, which is 185. (28 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 46.33 41 52 3
2020s 21.5 0 43 2

Countries ranked near Vanuatu

  1. 143 Saint Lucia 2 compare
  2. 143 Bermuda 2 compare
  3. 143 Andorra 2 compare
  4. 146 Grenada 0 compare
  5. 146 Niue 0
  6. 146 Mauritania 0 compare
  7. 146 Barbados 0 compare
  8. 146 Saint Kitts and Nevis 0 compare
  9. 146 Sao Tome and Principe 0 compare
  10. 146 South Sudan 0 compare
  11. 146 Antigua and Barbuda 0
  12. 146 Saint Vincent and the Grenadines 0 compare

See the full ranking of 157 places →

More health data for Vanuatu

All data for Vanuatu →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Vanuatu?
The number of people with susceptibility test result for rifampicin in Vanuatu was 0 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Vanuatu?
The highest recorded value was 52 in 2019.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Vanuatu?
The lowest recorded value was 0 in 2021.
How does Vanuatu rank for the number of people with susceptibility test result for rifampicin?
Vanuatu ranks 146th out of 155 countries with data for 2021.
Where does this Vanuatu data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Vanuatu. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/vanuatu/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/vanuatu/">The number of people with susceptibility test result for rifampicin in Vanuatu</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed